Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 73
- −8 vs. Q3 2024
- Portfolio value
- $3.37B
- −$155.3M (−4.4%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRDNViridian Therapeutics, Inc. | COM | 34,094 | $653.6K | <0.1% | +34,094 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 20,109 | $776.2K | <0.1% | +20,109 | New | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $2.27M | 0.1% | – | – | – |
| SKYESkye Bioscience, Inc. | COM NEW | 825,732 | $2.34M | 0.1% | +825,732 | New | History |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $2.61M | 0.1% | – | – | – |
| JBIOJade Biosciences, Inc. | COM | 1,440,499 | $3.82M | 0.1% | +1,440,499 | New | History |
| LUNGPulmonx Corp | COM | 752,541 | $5.11M | 0.2% | 00.0% | Unchanged | History |
| CBLLCeribell, Inc. | COM | 210,000 | $5.43M | 0.2% | +210,000 | New | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,472,806 | $6.18M | 0.2% | 00.0% | Unchanged | History |
| NVRONevro Corp | COM | 1,698,768 | $6.32M | 0.2% | 00.0% | Unchanged | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,225,448 | $6.83M | 0.2% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 884,306 | $11.6M | 0.3% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 802,100 | $11.9M | 0.4% | +802,100 | New | History |
| CADLCandel Therapeutics, Inc. | COM | 1,600,000 | $13.9M | 0.4% | +1,600,000 | New | History |
| XNCRXencor Inc | COM | 615,531 | $14.1M | 0.4% | +149,083+32.0% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,176,173 | $14.3M | 0.4% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 714,658 | $15.3M | 0.5% | +231,358+47.9% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 681,182 | $16.0M | 0.5% | +681,182 | New | History |
| Amphastar Pharmaceuticals IN03209RAB9 | NOTE 2.000% 3/1 | – | $16.3M | 0.5% | – | – | – |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $17.9M | 0.5% | – | – | – |
| REPLReplimune Group, Inc. | COM | 1,477,102 | $17.9M | 0.5% | −1,593,735−51.9% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 222,424 | $18.2M | 0.5% | −75,144−25.3% | Reduced | History |
| NUVLNuvalent, Inc. | COM | 241,235 | $18.9M | 0.6% | +241,235 | New | History |
| EXASExact Sciences Corp | COM | 353,000 | $19.8M | 0.6% | +66,822+23.3% | Added | History |
| BRKRBruker Corp | COM | 353,200 | $20.7M | 0.6% | +353,200 | New | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 5,440,277 | $24.1M | 0.7% | +1,002,045+22.6% | Added | History |
| GERNGeron Corp | COM | 7,006,315 | $24.8M | 0.7% | +7,006,315 | New | History |
| IMTXImmatics N.V. | SHS | 3,503,965 | $24.9M | 0.7% | +1,856,400+112.7% | Added | History |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $25.7M | 0.8% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 1,206,589 | $26.3M | 0.8% | +712,902+144.4% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,147,676 | $27.1M | 0.8% | +631,950+122.5% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 1,894,439 | $30.0M | 0.9% | +1,187,199+167.9% | Added | History |
| HROWHarrow, Inc. | COM | 907,039 | $30.4M | 0.9% | +467,401+106.3% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 200,500 | $31.4M | 0.9% | +31,809+18.9% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 2,000,659 | $34.9M | 1.0% | +343,059+20.7% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 309,865 | $35.3M | 1.0% | +62,115+25.1% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 4,256,490 | $39.1M | 1.2% | +215,425+5.3% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 75,300 | $39.3M | 1.2% | −16,000−17.5% | Reduced | History |
| FNAParagon 28, Inc. | COM | 3,834,809 | $39.6M | 1.2% | −300,300−7.3% | Reduced | History |
| RGENRepligen Corp | COM | 283,823 | $40.9M | 1.2% | −112,958−28.5% | Reduced | History |
| AVDLAvadel Pharmaceuticals PLC | Stock | 4,105,726 | $43.2M | 1.3% | +716,787+21.2% | Added | History |
| GKOSGLAUKOS Corp | COM | 288,876 | $43.3M | 1.3% | −22,740−7.3% | Reduced | History |
| PENPenumbra Inc | COM | 183,828 | $43.7M | 1.3% | −177,600−49.1% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 364,900 | $44.4M | 1.3% | −5,500−1.5% | Reduced | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 8,353,287 | $45.5M | 1.3% | 00.0% | Unchanged | History |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $46.0M | 1.4% | – | – | – |
| TMOThermo Fisher Scientific Inc. | Stock | 89,754 | $46.7M | 1.4% | +89,754 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 80,766 | $49.7M | 1.5% | −15,958−16.5% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 293,410 | $54.4M | 1.6% | +54,499+22.8% | Added | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $55.1M | 1.6% | – | – | – |
| TMDXTransMedics Group, Inc. | COM | 922,100 | $57.5M | 1.7% | +922,100 | New | History |
| VKTXViking Therapeutics, Inc. | COM | 1,479,666 | $59.5M | 1.8% | +322,689+27.9% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,578,404 | $60.0M | 1.8% | +388,568+17.7% | Added | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 4,873,853 | $61.8M | 1.8% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,332,196 | $62.3M | 1.8% | +373,886+19.1% | Added | History |
| IRTCiRhythm Holdings, Inc. | COM | 705,391 | $63.6M | 1.9% | −77,166−9.9% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 2,098,866 | $67.0M | 2.0% | −1,026,317−32.8% | Reduced | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 3,452,447 | $68.3M | 2.0% | +557,934+19.3% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 1,540,362 | $69.8M | 2.1% | −102,864−6.3% | Reduced | History |
| Dexcom Inc252131AM9 | NOTE 0.375% 5/1 | – | $74.4M | 2.2% | – | – | – |
| ALGNAlign Technology Inc | COM | 375,179 | $78.2M | 2.3% | +63,500+20.4% | Added | History |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $85.2M | 2.5% | – | – | – |
| GHGuardant Health, Inc. | COM | 2,847,931 | $87.0M | 2.6% | −494,193−14.8% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 3,283,317 | $94.2M | 2.8% | +112,442+3.5% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 2,977,951 | $96.9M | 2.9% | +1,436,400+93.2% | Added | History |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $98.3M | 2.9% | – | – | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $113.2M | 3.4% | – | – | – |
| XENEXenon Pharmaceuticals Inc. | COM | 2,913,964 | $114.2M | 3.4% | +206,709+7.6% | Added | History |
| Repligen Corp759916AD1 | NOTE 1.000%12/1 | – | $114.8M | 3.4% | – | New | – |
| NBIXNeurocrine Biosciences Inc | Stock | 901,790 | $123.1M | 3.6% | −15,884−1.7% | Reduced | History |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $134.5M | 4.0% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $148.1M | 4.4% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $226.0M | 6.7% | – | – | – |
Sold out since Q3 2024 (22)
Positions held at the end of Q3 2024 that are gone from this filing.
| Security | Class | Shares in Q3 2024 | Value in Q3 2024 | % of portfolio in Q3 2024 | History |
|---|---|---|---|---|---|
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $76.4M | 2.2% | – |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $53.5M | 1.5% | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 183,818 | $39.0M | 1.1% | History |
| ARVNArvinas, Inc. | COM | 1,284,472 | $31.6M | 0.9% | History |
| DXCMDexcom Inc | COM | 441,086 | $29.6M | 0.8% | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,499,427 | $24.8M | 0.7% | History |
| OCULOcular Therapeutix, Inc | COM | 2,239,770 | $19.5M | 0.6% | History |
| BSXBoston Scientific Corp | Stock | 189,200 | $15.9M | 0.4% | History |
| Haemonetics Corp Mass405024AB6 | NOTE 3/0 | – | $10.6M | 0.3% | – |
| ALECAlector, Inc. | COM | 2,158,245 | $10.1M | 0.3% | History |
| PODDInsulet Corp | Stock | 42,500 | $9.89M | 0.3% | History |
| CSTLCastle Biosciences Inc | COM | 331,986 | $9.47M | 0.3% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 298,400 | $7.60M | 0.2% | History |
| LXEOLexeo Therapeutics, Inc. | COM | 728,777 | $6.59M | 0.2% | History |
| SKINSkinHealth Systems Inc. | COM CL A | 4,049,694 | $5.83M | 0.2% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,069,158 | $3.82M | 0.1% | History |
| VERVVerve Therapeutics, Inc. | COM | 623,980 | $3.02M | 0.1% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 217,928 | $2.05M | 0.1% | History |
| HLVXHilleVax, Inc. | COM | 1,064,000 | $1.87M | 0.1% | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 801,584 | $1.26M | <0.1% | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,630,542 | $1.14M | <0.1% | History |
| ELEVElevation Acquisition Group Inc. | COM | 473,503 | $284.1K | <0.1% | History |